| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (methicillin-susceptible + 372/08) |
- |
- |
10 － ? |
Ag (nanoparticles suspension H)  |
936 |
| Staphylococcus aureus (methicillin-susceptible + ampicillin-resistant) |
1 |
2 |
0.5 － 4 |
Cefquinome |
1486 |
| Staphylococcus aureus (methicillin-susceptible + ampicillin-resistant) |
1 |
2 |
1 － 4 |
Cefpirome |
1486 |
| Staphylococcus aureus (methicillin-susceptible + ampicillin-resistant) |
4 |
8 |
2 － 16 |
Cefepime (Maxipime) |
1486 |
| Staphylococcus aureus (methicillin-susceptible + ampicillin-resistant) |
16 |
32 |
8 － 14 |
Ceftazidime (Ceptaz, Fortaz, Tanicef) |
1486 |
| Staphylococcus aureus (methicillin-susceptible + CAMHB + 25% bovine serum) |
8 |
8 |
4 － 8 |
Targocil |
1276 |
| Staphylococcus aureus (methicillin-susceptible + CAMHB + 25% bovine serum) |
>32 |
>32 |
>32 － ? |
1835F03 |
1276 |
| Staphylococcus aureus (methicillin-susceptible + CAMHB) |
1 |
2 |
1 － 2 |
Targocil |
1276 |
| Staphylococcus aureus (methicillin-susceptible + CAMHB) |
8 |
8 |
8 － >32 |
1835F03 |
1276 |
| Staphylococcus aureus (methicillin-susceptible + ciprofloxacin-resistant) |
0.5 |
0.5 |
≤0.06 － 2 |
Quinupristin/Dalfopristin (Synercid) |
21 |
| Staphylococcus aureus (methicillin-susceptible + ciprofloxacin-resistant) |
0.5 |
1 |
≤0.06 － 4 |
Quinupristin/Dalfopristin (Synercid) |
21 |
| Staphylococcus aureus (methicillin-susceptible + ciprofloxacin-resistant) |
16 |
64 |
4 － 64 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
21 |
| Staphylococcus aureus (methicillin-susceptible + ciprofloxacin-resistant) |
32 |
64 |
4 － >256 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
21 |
| Staphylococcus aureus (methicillin-susceptible + ciprofloxacin-susceptible) |
0.25 |
0.5 |
0.12 － 1 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
21 |
| Staphylococcus aureus (methicillin-susceptible + ciprofloxacin-susceptible) |
0.5 |
0.5 |
≤0.06 － 4 |
Quinupristin/Dalfopristin (Synercid) |
21 |
| Staphylococcus aureus (methicillin-susceptible + penicillin-resistant) |
0.06 |
0.06 |
0.008 － 2 |
Garenoxacin (T-3811, BMS-284756) |
102 |
| Staphylococcus aureus (methicillin-susceptible + penicillin-resistant) |
0.12 |
0.25 |
0.06 － 2 |
Moxifloxacin (BAY 12-8039, Avelox) |
102 |
| Staphylococcus aureus (methicillin-susceptible + penicillin-resistant) |
0.12 |
0.25 |
0.06 － 4 |
Gatifloxacin (Tequin) |
102 |
| Staphylococcus aureus (methicillin-susceptible + penicillin-resistant) |
0.25 |
0.5 |
0.25 － >32 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
102 |
| Staphylococcus aureus (methicillin-susceptible + penicillin-resistant) |
1 |
1 |
0.5 － 2 |
Amoxicillin-clavulanic acid (Augmentin) |
102 |
| Staphylococcus aureus (methicillin-susceptible + penicillin-resistant) |
2 |
2 |
1 － 4 |
Zosyn |
102 |
| Staphylococcus aureus (methicillin-susceptible + penicillin-resistant) |
4 |
4 |
4 － >32 |
Ceftriaxone (Rocephin) |
102 |
| Staphylococcus aureus (methicillin-susceptible + penicillin-resistant) |
- |
0.06 |
0.03 － 0.12 |
Imipenem |
102 |
| Staphylococcus aureus (methicillin-susceptible + penicillin-susceptible) |
0.06 |
0.06 |
0.015 － 0.06 |
Garenoxacin (T-3811, BMS-284756) |
102 |
| Staphylococcus aureus (methicillin-susceptible + penicillin-susceptible) |
0.12 |
0.25 |
0.06 － 0.25 |
Gatifloxacin (Tequin) |
102 |
| Staphylococcus aureus (methicillin-susceptible + penicillin-susceptible) |
0.12 |
0.25 |
0.06 － 0.5 |
Moxifloxacin (BAY 12-8039, Avelox) |
102 |
| Staphylococcus aureus (methicillin-susceptible + penicillin-susceptible) |
0.25 |
0.5 |
0.12 － 0.5 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
102 |
| Staphylococcus aureus (methicillin-susceptible + penicillin-susceptible) |
1 |
1 |
0.03 － 1 |
Amoxicillin-clavulanic acid (Augmentin) |
102 |